Jason Coloma V

Chief Executive Officer, Director, Maze Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$6.2M

Companies

Latest trade

Oct 1, 2026

Companies

Maze Therapeutics, Inc.Chief Executive Officer, Director −$6.2M

Trades

MAZE Sold 34,501 shares at $27.02 · planned $0.9M Oct 1

MAZE Sold 11,411 shares at $26.01 $0.3M Sep 3

MAZE Sold 11,227 shares at $26.47 $0.3M Sep 2

MAZE Sold 34,501 shares at $26.29 · planned $0.9M Sep 1

MAZE Sold 34,501 shares at $26.73 · planned $0.9M Aug 3

MAZE Sold 34,501 shares at $29.97 · planned $1.0M Jul 1

MAZE Sold 23,865 shares at $26.05 · planned $0.6M Jun 23

MAZE Sold 3,993 shares at $26.00 · planned $0.1M Jun 22

MAZE Sold 6,643 shares at $26.20 · planned $0.2M Jun 1

MAZE Sold 25,582 shares at $26.02 · planned $0.7M May 26

MAZE Sold 6,982 shares at $26.00 · planned $0.2M May 22

MAZE Sold 1,938 shares at $26.00 · planned $0.1M May 15

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.